This episode covers the latest in cybersecurity, from hackers using AI-powered phishing schemes to a new Phoenix Rowhammer attack targeting DDR5 memory. We dive into insider and financial data breaches, Microsoft’s Windows 10 end-of-support warning, and a surge of malicious WhiteCobra extensions in developer tools. Plus, we look at how AI is reshaping clinical trial site selection with major implications for data security.

AI Scams, Insider Threats, and New Cyber Attacks: This Week in Cybersecurity

Durable vision improvements were also observed out to 18 months for previously dosed adult patients in the trial.

Opus Reports Vision Improvements for Three Pediatric Patients in Phase 1/2 Clinical Trial for LCA5 Gene Therapy

Securing a timely EMA licence renewal is critical for any business operating electrical installations in Singapore. RES Engineering Services streamlines the process by managing inspections, documentation, and technical endorsements on your behalf. Led by a licensed electrical worker with more than 16 years of expertise, we have successfully completed hundreds of EMA licence renewal submissions since 2014. Our clients include factories, commercial buildings, and construction projects, all of which benefit from our precision and compliance-driven approach. In addition to renewals, we provide electrical consultancy, testing, and preventive maintenance to ensure systems remain safe and efficient year-round. Businesses trust RES Engineering Services for reliable, professional, and regulation-ready EMA renewal support.

EMA Licence Renewal Services in Singapore | RES Engineering

The emerging therapy improved vision for some participants in an earlier clinical trial.

Sepul Bio’s LCA10 RNA Therapy Moves into Phase 3 Clinical Trial

Cereno Scientific CEO Sten Sörensen discusses how his company is repurposing a 60-year-old epilepsy drug as a potential game-changer for pulmonary arterial hypertension and idiopathic pulmonary fibrosis. Learn about their promising Phase IIa results that showed improved heart function and reduced mortality risk, the FDA fast track designation they recently received, and their strategy for advancing two rare disease programs toward pivotal trials. A fascinating look at drug repurposing, epigenetic modulation, and the challenges of developing therapies for high unmet need patient populations.

Cereno Scientific Turns To Old Drug For Rare Cardiopulmonary Diseases

Join host David Wild as he speaks with Stacie Bell, chief clinical research officer at Lupus Therapeutics, about the dramatic transformation happening in lupus drug development. From a field once avoided by pharma companies to one generating unprecedented excitement, Bell discusses how her organization's 62-center network is revolutionizing clinical trials through patient engagement and scientific innovation.
 
Learn about promising oral therapies, Genentech's cancer drug Gazyva under FDA review for lupus nephritis, cell therapy approaches offering potential long-term remission and how combination treatments may become the new standard. Bell shares insights on overcoming clinical trial barriers, advancing biomarker research and ensuring representative participation from lupus communities.
 
A must-listen for anyone interested in autoimmune disease research, clinical development innovation, and patient-centered drug development.

Lupus Clinical Development Enters a New Era of Innovation

Biotech funding is tougher than ever, but some companies still win big. Join Claire Riches, VP, Clinical Solutions, Citeline and Alistair McDonald, CEO of Worldwide Clinical Trials as they reveal insider strategies for securing investors, navigating partnerships, and turning innovative science into real-world success.

View the video series and find out more information here: https://www.citeline.com/biotech

Winning Biotech Investors Through Strategic Partnerships and Trial Innovation

Want to explore clinical trials but unsure how to begin? Learn how to search for trials, what to expect when participating, and how barriers like cost or location are being addressed so more people can benefit.

About the speaker

Sara Horton, MD
Strategic Clinical Trials Access and Partnerships, Lead, Quantum Leap Healthcare Collaborative

Sara Horton, MD, a board-certified medical oncologist, currently holds the position of executive director of access and diversity at Quantum Leap Healthcare, a non-profit organization devoted to supporting breast cancer clinical trials. In addition, she holds an affiliate associate professorship at Howard University Cancer Center and serves as a medical oncologist for the Howard University Cancer Center Transdisciplinary Breast Cancer Clinic.

This is the final session of our four-part series, "Effective treatment & side effect support | Innovations in breast cancer care". When you’re facing breast cancer, understanding your options can make all the difference. This series brings together leading experts and patient advocates to help you speak up for your needs, manage side effects, and navigate treatment decisions with confidence.

This free, four-part webinar series is designed to help people with breast cancer — whether facing a new diagnosis, in treatment, or living with metastatic disease — get real answers to real challenges. Learn more about the series here: https://www.lbbc.org/community/events/innovations-in-care-2025

At Living Beyond Breast Cancer, we make sure people facing breast cancer have the support they need. We’re here with real answers, real stories, and real help—every step of the way. 

Follow us:
Facebook: https://www.facebook.com/livingbeyondbreastcancer
LinkedIn: https://www.linkedin.com/company/living-beyond-breast-cancer
Instagram: https://instagram.com/livingbeyondbc
YouTube: https://youtube.com/user/LBBC1991

Understand clinical trials: How to find one and what to expect | Innovations in breast cancer care

The approach may provide better visual acuity than current optogenetic therapies in clinical trials.

SparingVision Launches Clinical Trial for Therapy to Re-Activate Dormant Cones in Advanced RP

Micah returns to the conference world after twenty years, diving into the CDISC/TMF Interchange in Nashville. From acronyms to alignment debates, Suus and Micah unpack how the industry’s drive for standards collides with the messy, very human side of collaboration. Along the way: networking hacks, risk logs, Dutch “poldering,” and yes—chicken and waffles.

Conferencing Standards: From CDISC to Chicken & Waffles -  Inside the push to standardize TMFs—and rediscovering the human side of biotech.

Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.

The Daily HEAL Security Dispatch Podcast is a leading source for up-to-the-minute news and deep insights in the realm of healthcare cybersecurity and threat intelligence. 

At the heart of HEAL Security's vision is the commitment to equipping organizations and individuals with rapid, contextually rich cybersecurity updates, establishing itself as a pivotal force in unifying practice and data against the ingenious tactics of criminal and malicious entities. HEAL Security is fervently devoted to constructing a robust resource and community that champions the defense of the healthcare sector against the growing cyber threats from organized crime groups and antagonistic nation-states. Our core focus encompasses the protection of vital IT infrastructures, the security of sensitive patient and clinical information, the safeguarding of critical healthcare systems, and the assurance of continuous, undisturbed patient care services.

Living Beyond Breast Cancer is a national nonprofit organization that seeks to create a world that understands there is more than one way to have breast cancer. To fulfill our mission of providing trusted information and a community of support, we offer on-demand emotional, practical, and evidence-based content that is meaningful to those newly diagnosed, in treatment, post-treatment, and living with metastatic disease.

In Can and Did Conversations, young women diagnosed with breast cancer share their stories about the impact of breast cancer and what they did to steer a path forward in this limited podcast series. Topics that matter, such as navigating mental health conditions, career and workplace decisions, complementary therapies, and fertility issues are discussed.

The Foundation Fighting Blindness is the driving force in the global development of treatments and cures for blinding diseases. To learn more, go to FightingBlindness.org.

New tracks tagged #ClinicalTrials